With 5-7% of Women world wide experiencing Pre-eclampsia a definative test would become the de facto "gold standard" for screening ALL PREGNANT WOMEN.  That's a lot of tests each year and such a test would be worth hundreds of milllions / year to Alere.  What would MOM's cut be?  Even if it were just 5% it would make us a $5.00-$10.00 stock.  Why are we trading at $.10?

http://finance.yahoo.com/news/alere-secures-final-option-period-110000465.html

 

Hot